Therapeutic trials for systemic sclerosis: an update.
Indian J Dermatol Venereol Leprol
;
2008 Sep-Oct; 74(5): 436-46
Artículo
en Inglés
| IMSEAR
| ID: sea-52840
ABSTRACT
The pathogenesis of systemic sclerosis (SSc) is complex, and the final story is yet to be elucidated. The clinical heterogeneity of the disease, its various autoimmune and antibody profiles, its long course and tendency for spontaneous cure makes the design of clinical trials difficult. The overwhelming need in this disease is to diagnose it early and identify those patients who will benefit most from early, aggressive treatment. We attempt to review data from recent clinical trials and the lessons derived.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Idioma:
Inglés
Revista:
Indian J Dermatol Venereol Leprol
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS